1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Kevin Cooper MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma silicon phthalocyanine 4, photodynamic therapy, pharmacological study - Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome | Phase 1 | Completed | Kevin Cooper MD | 11 | 2013-04-01 | 2019-05-16 |
Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1) · Sezary Syndrome (1)
1-phenyl-3,3-dimethyltriazene (1) · Photochemotherapy (1) · SUB1 protein, human (1)
United States (1)
Elma Baron, MD (1)